The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus

Innate Immunity

Volumn 23, Issue 2, 2017, Pages 196-205

  Hellum, Marit ^a   Trøseid, Anne Marie S ^b   Berg, Jens P ^a,b   Brandtzaeg, Petter ^a,b   Øvstebø, Reidun ^b   Henriksson, Carola E ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

lpxL1 mutant; Microvesicles; monocytes; Neisseria meningitidis; sepsis; tissue factor

Indexed keywords

LIPID A; MESSENGER RNA; THROMBIN; THROMBOPLASTIN; ACYLTRANSFERASE; BACTERIAL PROTEIN; LPXL PROTEIN, BACTERIA;

APOPTOSIS; ARTICLE; BACTERIAL GENE; BLOOD CLOTTING; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LPXL1 GENE; MEMBRANE MICROPARTICLE; MENINGOCOCCOSIS; MONOCYTE; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; CELL CULTURE; DISEASE COURSE; GENETICS; IMMUNOLOGY; INFLAMMATION; MENINGITIS; METABOLISM; MICROBIOLOGY; MUTATION; PRIMARY CELL CULTURE; SEPSIS;

ACYLTRANSFERASES; BACTERIAL PROTEINS; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DISEASE PROGRESSION; HUMANS; INFLAMMATION; MENINGITIS; MONOCYTES; MUTATION; NEISSERIA MENINGITIDIS; PRIMARY CELL CULTURE; SEPSIS; THROMBOPLASTIN;

EID: 85011407733     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425916684201     Document Type: Article

References (38)

1. Stephens DS, Greenwood B, Brandtzaeg P,. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369: 2196-2210.
2. Rapaport SI, Rao LV,. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121.
3. Levi M,. Disseminated intravascular coagulation: What's new? Crit Care Clin 2005; 21: 449-467.
4. Osterud B, Bjorklid E,. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 605-617.
5. Osterud B, Flaegstad T,. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
6. Hellum M, Ovstebo R, Brusletto BS, et al. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock. Thromb Res 2014; 133: 507-514.
7. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930-935.
8. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-2688.
9. Gregory SA, Morrissey JH, Edgington TS,. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-2755.
10. van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-1259.
11. Beutler B, Hoebe K, Du X, Ulevitch RJ,. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003; 74: 479-485.
12. Steeghs L, Tommassen J, Leusen JH, et al. Teasing apart structural determinants of 'toxicity' and 'adjuvanticity': implications for meningococcal vaccine development. J Endotoxin Res 2004; 10: 113-119.
13. Zughaier SM, Lindner B, Howe J, et al. Physicochemical characterization and biological activity of lipooligosaccharides and lipid A from Neisseria meningitidis. J Endotoxin Res 2007; 13: 343-357.
14. Pupo E, Hamstra HJ, Meiring H, van der Ley P,. Lipopolysaccharide engineering in Neisseria meningitidis: structural analysis of different pentaacyl lipid A mutants and comparison of their modified agonist properties. J Biol Chem 2014; 289: 8668-8680.
15. van der Ley P, Steeghs L, Hamstra HJ, et al. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun 2001; 69: 5981-5990.
16. Brouwer MC, Spanjaard L, Prins JM, et al. Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide. J Infect 2011; 62: 479-483.
17. Rodenburg GD, Fransen F, Bogaert D, et al. Prevalence and clinical course in invasive infections with meningococcal endotoxin variants. PLOS ONE 2012; 7: e49295-e49295.
18. Fransen F, Heckenberg SG, Hamstra HJ, et al. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLOS Pathog 2009; 5: e1000396-e1000396.
19. du Plessis M, Wolter N, Crowther-Gibson P, et al. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect 2014; 68: 455-461.
20. Holten E,. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol 1979; 9: 186-188.
21. van der Ley P, van den Dobbelsteen G,. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Human Vaccines 2011; 7: 886-890.
22. Steeghs L, den Hartog R, den Boer A, et al. Meningitis bacterium is viable without endotoxin. Nature 1998; 392: 449-450.
23. Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000; 287: 1809-1815.
24. Lund PK, Joo GB, Westvik AB, et al. Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest 2000; 60: 357-365.
25. Crescitelli R, Lasser C, Szabo TG, et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2013; Sep 12;2. doi: 10.3402/jev.v2i0.20677.
26. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
27. Debaugnies F, Azerad M-A, Noubouossié D, et al. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res 2010; 126: 531-535.
28. Hemker HC, Kremers R,. Data management in thrombin generation. Thromb Res 2013; 131: 3-11.
29. Amundsen EK, Urdal P, Holthe MR, Henriksson CE,. Aggregation of monocytes and platelets interferes in measurement of monocyte viability with phosphatidylserine expression but not with mitochondrial membrane potential in whole blood. Cytometry B Clin Cytom 2015. doi: 10.1002/cyto.b.21189.
30. Piehler AP, Grimholt RM, Ovstebo R, Berg JP,. Gene expression results in lipopolysaccharide-stimulated monocytes depend significantly on the choice of reference genes. BMC Immunol 2010; 11: 21-21.
31. Hackett SJ, Guiver M, Marsh J, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 2002; 86: 44-46.
32. Ovstebo R, Brandtzaeg P, Brusletto B, et al. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42: 2980-2987.
33. Egorina EM, Sovershaev MA, Bjorkoy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 2005; 25: 1493-1498.
34. Malarstig A, Siegbahn A,. The intersubject variability of tissue factor mRNA production in human monocytes-relation with the toll-like receptor 4. Thromb Res 2007; 120: 407-413.
35. Sprong T, Stikkelbroeck N, van der Ley P, et al. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 2001; 70: 283-288.
36. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA,. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-1611.
37. Uronen H, Williams AJ, Dixon G, et al. Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS). Clin Exp Immunol 2000; 122: 312-315.
38. Sprong T, Ley P, Abdollahi-Roodsaz S, et al. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production. Innate Immun 2011; 17: 517-525.